APA (7th ed.) Citation

CE, V., W, T., G, D., SN, S., AW, B., P, S., . . . M, W. (2013). Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age. Leukemia research, 37(11), 1468. https://doi.org/10.1016/j.leukres.2013.07.036

Chicago Style (17th ed.) Citation

CE, Vigil, et al. "Phase II Trial of Clofarabine and Daunorubicin as Induction Therapy for Acute Myeloid Leukemia Patients Greater than or Equal to 60 Years of Age." Leukemia Research 37, no. 11 (2013): 1468. https://doi.org/10.1016/j.leukres.2013.07.036.

MLA (9th ed.) Citation

CE, Vigil, et al. "Phase II Trial of Clofarabine and Daunorubicin as Induction Therapy for Acute Myeloid Leukemia Patients Greater than or Equal to 60 Years of Age." Leukemia Research, vol. 37, no. 11, 2013, p. 1468, https://doi.org/10.1016/j.leukres.2013.07.036.